Toxicities in immunotherapy: Can they predict response?-Reference-Cited by-同舟云学术

Toxicities in immunotherapy: Can they predict response?

Published:2016-05-20 Issue:15_suppl Volume:34 Page:e14534-e14534
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Prior Lisa Mary¹,Harrold Emily¹,O'Leary Connor Gerard¹,Nugent Killian²,Gleeson Jack Patrick³,Watson Geoffrey Alan¹,Lim Marvin Chang Jui¹,Kelly Deirdre⁴,McCaffrey John⁴,Kelly Catherine Margaret¹

Affiliation:

1. Mater Misericordiae University Hospital, Dublin, Ireland;

2. Mater Misericordiae, Dublin, Ireland;

3. MMUH, Dublin, Ireland;

4. Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin, Ireland;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.e14534

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors;American Journal of Clinical Dermatology;2022-06-16

3. Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis;F1000Research;2020-09-23

4. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy;World Neurosurgery;2020-07

5. One dose of immunotherapy leading to an exceptional and durable response in a patient with metastatic renal cell carcinoma;Oxford Medical Case Reports;2019-12